Co-Authors
This is a "connection" page, showing publications co-authored by Fumihiro Ogawa and Mototsugu Nishii.
Connection Strength
0.357
-
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb J. 2021 Aug 16; 19(1):55.
Score: 0.241
-
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022.
Score: 0.060
-
Serum cholinesterase associated with COVID-19 pneumonia severity and mortality. J Infect. 2021 02; 82(2):282-327.
Score: 0.056